Xeris Pharmaceuticals





Ebitda Cambio Fecha
Celltrion KRW 374.56B 352.67B 2025-09
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 15.51M 3.39M 2025-06
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
Organigram Holdings CAD 6.15M 455K 2025-09
Pacira USD 49.36M 4.96M 2025-09
Perrigo USD 258.8M 37.3M 2025-09
Pharma Mar EUR -1.98M 28.13M 2025-09
Qiagen NV USD 249.69M 56.53M 2025-12
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Supernus Pharmaceuticals USD 41.9M 432K 2025-09
Tilray USD 8.36M 1.82M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06


Xeris Pharmaceuticals - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.